Skip to main content

Table 1 Baseline characteristics of the propensity-matched patients of the Redo-TAVI and Redo-AVR group

From: Propensity matched analysis of longterm outcomes following transcatheter based aortic valve implantation versus classic aortic valve replacement in patients with previous cardiac surgery

 

All patients

Propensity-matched patients

 

Redo-TAVI (n = 52)

Redo-AVR (n = 167)

 

Redo-TAVI (n = 40)

Redo-AVR (n = 40)

 

Variables

No. (%)

No. (%)

p value

No. (%)

No. (%)

p value

Age (years)

82 ± 5

72 ± 9

0.07

81 ± 4

80 ± 3

>0.99

Log EuroSCORE||

25 ± 5

17 ± 2

0.11

24 ± 6

19 ± 6

0.58

STS risk score

11 ± 4

9 ± 2

0.07

11.1 ± 2.8

10.4 ± 3

0.65

Male

31 (60)

92 (55)

0.44

29 (73)

29 (73)

>0.99

Arterial hypertension

22 (42)

106 (63)

0.14

16 (40)

18 (45)

0.69

Pulmonary hypertension

16 (31)

72 (43)

0.24

5 (13)

5 (13)

>0.99

Diabetes

20 (38)

43 (26)

0.42

17 (42)

14 (35)

0.54

CAD

45 (87)

42 (25)

0.03

33 (83)

30 (75)

0.46

COPD§

19 (36)

37 (22)

0.67

9 (23)

8 (20)

0.81

Chronic renal failure*

30 (58)

21 (12)

0.05

20 (50)

16 (40)

0.43

Peripheral vascular disease

23 (44)

24 (14)

0.04

13 (33)

11 (27)

0.43

Cerebrovascular disease

20 (38)

31 (18)

0.07

9 (23)

8 (20)

0.81

LV-EF < 30

21 (40)

39 (23)

0.06

9 (23)

9 (23)

>0.99

Mean ejection fraction

39 ± 18

44 ± 14

0.62

48 ± 14

47 ± 12

0.77

Aortic valve area (cm)

0.65 ± 0.24

0.5 ± 0.31

0.46

0.63 ± 0.29

0.68 ± 0.31

0.65

Mean pressure gradient (echo; mmHg)

59 ± 18

57 ± 14

0.59

57 ± 21

51 ± 16

0.56

Peak to peak gradient (invasive; mmHg)

67 ± 27

70 ± 35

0.55

69 ± 36

65 ± 34

0.58

Mean time interval between initialand current cardiac procedure (years)

7 ± 4

11 ± 8

0.60

7 ± 5

8 ± 6

0.78

  1. CAD = coronary artery disease; §COPD = chronic obstructive pulmonary disease; ||EuroSCORE = European system for cardiac risk evaluation; LV-EF = left ventricular ejection fraction.